Skip to main content

Nucynta FDA Approval History

FDA Approved: Yes (First approved November 20, 2008)
Brand name: Nucynta
Generic name: tapentadol
Dosage form: Tablets
Company: Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Treatment for: Pain

Nucynta (tapentadol) is a centrally acting oral analgesic indicated for the relief of moderate to severe acute pain.

Development timeline for Nucynta

DateArticle
Aug 29, 2012Approval FDA Approves Nucynta ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Aug 26, 2011Approval Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Nov 21, 2008Approval FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
Jan 24, 2008New Drug Application Submitted to FDA for Investigational AnalgesicTapentadol Immediate Release Tablets

See also

Nucynta (tapentadol) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer